Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention

被引：0
|
作者：
Reinder Evertz
Tessa van der Heijden
Rypko Beukema
Sjoerd Westra
Esther Meindersma
Caroline van Deursen
Kevin Vernooy
机构：
[1] Radboud University Medical Centre,Department of Cardiology
[2] Maastricht University Medical Centre,Department of Cardiology, Cardiovascular Research Institute Maastricht
来源：
Netherlands Heart Journal | 2023年 / 31卷
关键词：
Implantable cardioverter-defibrillator therapy; Primary prevention; Secondary prevention; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：348 / 356
页数：8
相关论文
共 50 条
  • [1] Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
    Evertz, Reinder
    van der Heijden, Tessa
    Beukema, Rypko
    Westra, Sjoerd
    Meindersma, Esther
    van Deursen, Caroline
    Vernooy, Kevin
    [J]. NETHERLANDS HEART JOURNAL, 2023, 31 (09) : 348 - 356
  • [2] Update on primary prevention implantable cardioverter-defibrillator therapy
    Epstein A.E.
    [J]. Current Cardiology Reports, 2009, 11 (5) : 335 - 342
  • [3] Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication
    Schaer, Beat
    Kuehne, Michael
    Reichlin, Tobias
    Osswald, Stefan
    Sticherling, Christian
    [J]. EUROPACE, 2016, 18 (02): : 227 - 231
  • [4] Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
    Sarrias, Axel
    Galve, Enrique
    Sabate, Xavier
    Moya, Angel
    Anguera, Ignacio
    Nunez, Elaine
    Villuendas, Roger
    Alcalde, Oscar
    Garcia-Dorado, David
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (06): : 492 - 496
  • [5] Impact of Implantable Cardioverter-Defibrillator Therapy on a Secondary Prevention Population
    Rathod, Ankit
    Badheka, Apurva
    Deshmukh, Abhishek
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (22) : 2093 - 2094
  • [6] Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary Prevention
    Bhonsale, Aditya
    James, Cynthia A.
    Tichnell, Crystal
    Murray, Brittney
    Gagarin, Dmitri
    Philips, Binu
    Dalal, Darshan
    Tedford, Ryan
    Russell, Stuart D.
    Abraham, Theodore
    Tandri, Harikrishna
    Judge, Daniel P.
    Calkins, Hugh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (14) : 1485 - 1496
  • [7] Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes
    Pick, Justin M.
    Batra, Anjan S.
    [J]. CARDIOLOGY IN THE YOUNG, 2017, 27 : S126 - S131
  • [8] Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
    Christian Hauck
    Andreas Schober
    Alexander Schober
    Sabine Fredersdorf-Hahn
    Ute Hubauer
    Andreas Keyser
    Lars Maier
    Carsten Jungbauer
    Ekrem Ücer
    [J]. Aging Clinical and Experimental Research, 2022, 34 : 1073 - 1080
  • [9] Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
    Hauck, Christian
    Schober, Andreas
    Schober, Alexander
    Fredersdorf-Hahn, Sabine
    Hubauer, Ute
    Keyser, Andreas
    Maier, Lars
    Jungbauer, Carsten
    Uecer, Ekrem
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (05) : 1073 - 1080
  • [10] Impact of Implantable Cardioverter-Defibrillator Therapy on a Secondary Prevention Population Reply
    Borne, Ryan T.
    Varosy, Paul D.
    Masoudi, Frederick A.
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (22) : 2094 - 2094
12345